Net Loss Per Share Attributable to Guardant Health, Inc. Common Stockholders (Tables)

6 Months Ended

Jun. 30, 2020

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of the basic and diluted net loss per share attributable to Guardant Health, Inc. common stockholders:


	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019

	(unaudited)
	(in thousands, except per share data)
Net loss	$	(49,739)	$	(11,300)	$	(81,568)	$	(32,651)
Adjustment of redeemable noncontrolling interest	(4,900)		(300)		(800)		(5,000)
Net loss attributable to Guardant Health, Inc. common stockholders, basic and diluted	$	(54,639)	$	(11,600)	$	(82,368)	$	(37,651)
Net loss per share attributable to Guardant Health, Inc. common stockholders, basic and diluted	$	(0.57)	$	(0.13)	$	(0.87)	$	(0.43)
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, basic and diluted	96,011		89,036		95,196		87,494

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to Guardant Health, Inc. common stockholders for the periods presented as they had an anti-dilutive effect:


	Three Months Ended June 30,			Six Months Ended June 30,
	2020	2019	2020	2019

	(unaudited)
	(in thousands)
Stock options issued and outstanding	4,056	6,313	4,200	6,908
Restricted stock units	542	122	519	100
MSUs	1,342	—	671	—
ESPP obligation	37	83	40	71
Common stock subject to repurchase	20	32	21	37
Total	5,997	6,550	5,451	7,116